Mostrar el registro sencillo del ítem

Artículo

dc.creatorvan Dinther, Maartenes
dc.creatorCunningham, Kyle T.es
dc.creatorSingh, Shashi Prakashes
dc.creatorWhite, Madeleine P.J.es
dc.creatorCampion, Tiffanyes
dc.creatorCiancia, Clairees
dc.creatorvan Veelen, Peter A.es
dc.creatorde Ru, Arnoud H.es
dc.creatorGonzález Prieto, Románes
dc.creatorMukundan, Ananyaes
dc.creatorMaizels, Rick M.es
dc.date.accessioned2024-02-14T15:02:36Z
dc.date.available2024-02-14T15:02:36Z
dc.date.issued2023
dc.identifier.citationvan Dinther, M., Cunningham, K.T., Singh, S.P., White, M.P.J., Campion, T., Ciancia, C.,...,Maizels, R.M. (2023). CD44 Acts as a Coreceptor for Cell-specific Enhancement of Signaling and Regulatory T Cell Induction by TGM1, a Parasite TGF-β Mimic. Proceedings of the National Academy of Sciences of the United States of America, 120 (34), e2302370120. https://doi.org/10.1073/pnas.2302370120.
dc.identifier.issn0027-8424es
dc.identifier.issn1091-6490es
dc.identifier.urihttps://hdl.handle.net/11441/155242
dc.description.abstractLong-lived parasites evade host immunity through highly evolved molecular strategies. The murine intestinal helminth, Heligmosomoides polygyrus, down-modulates the host immune system through release of an immunosuppressive TGF-β mimic, TGM1, which is a divergent member of the CCP (Sushi) protein family. TGM1 comprises 5 domains, of which domains 1-3 (D1/2/3) bind mammalian TGF-β receptors, acting on T cells to induce Foxp3+ regulatory T cells; however, the roles of domains 4 and 5 (D4/5) remain unknown. We noted that truncated TGM1, lacking D4/5, showed reduced potency. Combination of D1/2/3 and D4/5 as separate proteins did not alter potency, suggesting that a physical linkage is required and that these domains do not deliver an independent signal. Coprecipitation from cells treated with biotinylated D4/5, followed by mass spectrometry, identified the cell surface protein CD44 as a coreceptor for TGM1. Both full-length and D4/5 bound strongly to a range of primary cells and cell lines, to a greater degree than D1/2/3 alone, although some cell lines did not respond to TGM1. Ectopic expression of CD44 in nonresponding cells conferred responsiveness, while genetic depletion of CD44 abolished enhancement by D4/5 and ablated the ability of full-length TGM1 to bind to cell surfaces. Moreover, CD44-deficient T cells showed attenuated induction of Foxp3 by full-length TGM1, to levels similar to those induced by D1/2/3. Hence, a parasite protein known to bind two host cytokine receptor subunits has evolved a third receptor specificity, which serves to raise the avidity and cell type–specific potency of TGF-β signaling in mammalian cells.es
dc.description.sponsorshipWellcome Trust 219530es
dc.description.sponsorshipWellcome Centre for Integrative Parasitology 10411es
dc.description.sponsorshipNational Institutes of Health AI153915, AI57069es
dc.formatapplication/pdfes
dc.format.extent12 p.es
dc.language.isoenges
dc.publisherNational Academy of Scienceses
dc.relation.ispartofProceedings of the National Academy of Sciences of the United States of America, 120 (34), e2302370120.
dc.rightsAttribution-NonCommercial-NoDerivatives 4.0 Internacional*
dc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/4.0/*
dc.subjectComplement control proteines
dc.subjectConvergent evolutiones
dc.subjectFibroblastes
dc.subjectHeligmosomoides polygyruses
dc.subjectT lymphocytees
dc.titleCD44 Acts as a Coreceptor for Cell-specific Enhancement of Signaling and Regulatory T Cell Induction by TGM1, a Parasite TGF-β Mimices
dc.typeinfo:eu-repo/semantics/articlees
dc.type.versioninfo:eu-repo/semantics/publishedVersiones
dc.rights.accessRightsinfo:eu-repo/semantics/openAccesses
dc.contributor.affiliationUniversidad de Sevilla. Departamento de Biología Celulares
dc.relation.projectID219530es
dc.relation.projectID10411es
dc.relation.projectIDAI153915es
dc.relation.projectIDAI57069es
dc.relation.publisherversionhttps://dx.doi.org/10.1073/pnas.2302370120es
dc.identifier.doi10.1073/pnas.2302370120es
dc.journaltitleProceedings of the National Academy of Sciences of the United States of Americaes
dc.publication.volumen120es
dc.publication.issue34es
dc.publication.initialPagee2302370120es
dc.contributor.funderWellcome Trust. Reino Unido.es
dc.contributor.funderWellcome Centre for Integrative Parasitology. Reino Unido.es
dc.contributor.funderNational Institutes of Health (NIH). EE.UU.es

FicherosTamañoFormatoVerDescripción
CD44 acts.pdf1.810MbIcon   [PDF] Ver/Abrir  

Este registro aparece en las siguientes colecciones

Mostrar el registro sencillo del ítem

Attribution-NonCommercial-NoDerivatives 4.0 Internacional
Excepto si se señala otra cosa, la licencia del ítem se describe como: Attribution-NonCommercial-NoDerivatives 4.0 Internacional